PROF: Profound Medical Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
Stocks in this Quantisnow insightHealth Care
Historical context for PROF
Across the 14 sessions after earlier PROF headlines, the stock closed higher 9 times and lower 5 times, with a median move of 2.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | PROF | SPY |
|---|---|---|---|
| Jan 28, 2026 | Profound Medical Announces Upcoming Investor Events | -2.3% | -0.0% |
| Jan 15, 2026 | Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO® | +9.4% | +0.3% |
| Jan 12, 2026 | Profound Surpasses 2025 TULSA-PRO® Installed Base Goal | +2.5% | +0.2% |
| Jan 6, 2026 | Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case | -0.5% | +0.6% |
| Dec 31, 2025 | Profound Medical Corp. Announces Closing of Private Placement | +7.4% | -0.7% |
| Dec 24, 2025 | Profound Medical Corp. Announces Upsize of Private Placement | +1.5% | +0.4% |
Quantisnow market dataNASDAQ
PROF
Profound Medical Corp.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
Get push alerts for PROF
Full PROF profile on Quantisnow Follow PROF and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time